Différences
Ci-dessous, les différences entre deux révisions de la page.
Les deux révisions précédentes Révision précédente | Prochaine révisionLes deux révisions suivantes | ||
ecolopol:covid19 [2020/04/26 19:01] – [Quelques soutiens notables au Pr Didier Raoult] Grégory Gutierez | ecolopol:covid19 [2020/04/27 09:15] – [Données et retours d'expériences autour de l'hydroxychloroquine] Grégory Gutierez | ||
---|---|---|---|
Ligne 340: | Ligne 340: | ||
===== Données et retours d' | ===== Données et retours d' | ||
+ | |||
+ | ^[[https:// | ||
+ | |Speed is crucial in the hunt for COVID-19 treatments, and a slow-down in clinical trials could cost lives. Some people don’t want to participate in clinical trials that would require them to give up chloroquine treatments. This has made it difficult to enrol people into his trial of HIV drugs as potential COVID-19 treatments, says infectious-disease specialist Sung-Han Kim at the University of Ulsan College of Medicine in Seoul. (...) Data from clinical trials can also be skewed by excluding participants who refuse to give up chloroquine treatment. Chloroquine can cause heart arrhythmias, | ||
^[[https:// | ^[[https:// |